BACTERIAL VECTOR

Patent №

US 8,093,025

Granted

2012-01-10

Filed 2007

Owner

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11667034

The present invention relates to a combination of compounds for introducing nucleic acids and/or protein into animal cells, tissue, organs or organisms in vitro, extracorporal, or in vivo. This combination comprises preparations suitable for administration to an animal or human for medical purposes, comprising as one component a bacterial vector genetically manipulated to contain nucleic acid sequences comprising a transgene, and a second component for the subsequent transcription, possibly translation of the transgene by controlled induction of bacterial vector as it is present within the animal or human.

AI hardwareC12N 15/70A61P 1/04A61P 5/00A61P 25/28A61P 31/00A61P 31/04A61P 31/12A61P 33/00+8 more

AI classification

AI hardware0.70
Natural language0.00
Machine learning0.00
Speech0.00
Evolutionary computation0.00
Vision0.00
Knowledge representation0.00
Planning0.00

Ownership

HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH

assignment · 196330115

Assignors

LOESSNER, HOLGER, ENDMANN, ANNE, LESCHNER, SARA, WEISS, SIEGFRIED

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC